-
公开(公告)号:WO2009006492A2
公开(公告)日:2009-01-08
申请号:PCT/US2008068951
申请日:2008-07-02
Applicant: SQUIBB BRISTOL MYERS CO , HANSON RONALD L , GOSWAMI ANIMESH , DAVIS BRIAN L , PARKER WILLIAM LAWRENCE , PATEL RAMESH N
Inventor: HANSON RONALD L , GOSWAMI ANIMESH , DAVIS BRIAN L , PARKER WILLIAM LAWRENCE , PATEL RAMESH N
IPC: C12P13/00
CPC classification number: C12P13/001 , C12P41/003 , C12P41/006
Abstract: The invention relates to processes for the enzymatic, stereoselective resolution of racemic amines to provide chiral amines.
Abstract translation: 本发明涉及外消旋胺的酶促立体选择性拆分以提供手性胺的方法。
-
公开(公告)号:WO03016543A3
公开(公告)日:2003-07-24
申请号:PCT/US0226810
申请日:2002-08-21
Applicant: SQUIBB BRISTOL MYERS CO , PATEL RAMESH N
Inventor: PATEL RAMESH N
IPC: C07D205/08 , C07D305/14 , C12P17/02 , C12P17/10 , C12P41/00
CPC classification number: C12P17/02 , C07D205/08 , C07D305/14 , C12P17/10 , C12P41/004
Abstract: A method for the resolution of a mixture of the cis or trans enantiomers of a compound of the formula [insert chemical structure] wherein R1 is -O-C(O)alkyl, -O-C(O)aryl or -O-C(O)cycloalkyl by contacting the mixture with a carboxylic ester hydrolase enzyme which catalyzes the stereoselective hydrolysis of the mixture and the use of such enantiomers to produce antitumor compounds which are especially suitable for oral administration.
Abstract translation: 一种拆分式[插入化学结构]的化合物的顺式或反式对映体混合物的方法,其中R1是-OC(O)烷基,-OC(O)芳基或-OC(O) 与催化混合物的立体选择性水解的羧酸酯水解酶的混合物以及使用这种对映异构体产生特别适用于口服给药的抗肿瘤化合物。
-
3.CYCLIC 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS 审中-公开
Title translation: 循环11-羟基脱氢酶脱氢酶I型抑制剂公开(公告)号:WO2008024892A3
公开(公告)日:2008-12-11
申请号:PCT/US2007076593
申请日:2007-08-23
Applicant: SQUIBB BRISTOL MYERS CO , YE XIANG-YANG , ROBL JEFFREY A , HANSON RONALD L , GUO ZHIWEI , PATEL RAMESH N
Inventor: YE XIANG-YANG , ROBL JEFFREY A , HANSON RONALD L , GUO ZHIWEI , PATEL RAMESH N
IPC: C07C61/39 , C07C57/00 , C07C59/00 , C07C61/40 , C07C62/38 , C07D203/18 , C07D205/04 , C07D205/08 , C07D263/04 , C07D263/30 , C07D295/18 , C07D317/72 , C07D451/02 , C07D493/08
CPC classification number: C07C61/40 , C07B2200/07 , C07C57/50 , C07C57/62 , C07C59/54 , C07C59/56 , C07C59/72 , C07C59/88 , C07C61/39 , C07C62/38 , C07C2603/66 , C07C2603/74 , C07D203/18 , C07D205/04 , C07D205/06 , C07D207/12 , C07D207/14 , C07D207/16 , C07D211/42 , C07D211/46 , C07D213/40 , C07D217/02 , C07D241/08 , C07D257/04 , C07D261/02 , C07D261/08 , C07D263/04 , C07D277/04 , C07D277/46 , C07D277/64 , C07D277/82 , C07D285/135 , C07D295/185 , C07D295/205 , C07D401/12 , C07D403/04 , C07D407/06 , C07D413/04 , C07D471/04 , C07D493/08
Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure (I) enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.
Abstract translation: 提供了新的化合物,其为11-β-羟基类固醇脱氢酶I型抑制剂。 11-β-羟基类固醇脱氢酶I型抑制剂可用于治疗,预防或减缓需要11-β-羟基类固醇脱氢酶I型抑制剂治疗的疾病进展。 这些新化合物具有其结构(I)对映异构体,非对映体,溶剂合物或其盐,其中A,W,X和Z如本文所定义。
-
4.ENZYMATIC PREPARATION OF (S) AMINO ACID FROM (R,S) AMINO ACID OR FROM KETO ACID 审中-公开
Title translation: (R,S)氨基酸或酮酸的(S)氨基酸的酶促制备公开(公告)号:WO2007112299A3
公开(公告)日:2008-03-13
申请号:PCT/US2007064767
申请日:2007-03-23
Applicant: SQUIBB BRISTOL MYERS CO , PATEL RAMESH N , CHEN YIJUN , GOLDBERG STEVEN L , HANSON RONALD L , GILL IQBAL , GOSWAMI ANIMESH , TULLY THOMAS P , PARKER WILLIAM LAWRENCE
Inventor: PATEL RAMESH N , CHEN YIJUN , GOLDBERG STEVEN L , HANSON RONALD L , GILL IQBAL , GOSWAMI ANIMESH , TULLY THOMAS P , PARKER WILLIAM LAWRENCE
IPC: C12N15/53 , C07D213/55 , C12N1/21 , C12N9/06 , C12N9/10 , C12N15/54 , C12N15/63 , C12P13/04 , C12P17/12 , C12P41/00
CPC classification number: C12N9/1096 , C07D213/55 , C12N9/0016 , C12P13/04 , C12P17/12 , C12P41/002
Abstract: Disclosed and claimed herein are novel biocatalysts for converting racemic mixtures of amino acids to an enantiomerically pure (S) form of the amino acid, methods for their use, and the enantiomerically enriched products of such biocatalytic processes.
Abstract translation: 本文公开和要求保护的是用于将氨基酸的外消旋混合物转化为对映体纯的(S)形式的氨基酸的新型生物催化剂,其使用方法以及这些生物催化方法的对映异构体富集的产物。
-
5.N-CARBOBENZYLOXY (N-CBZ)-DEPROTECTING ENZYME AND USES THEREFOR 审中-公开
Title translation: N-羧酸(N-CBZ) - 保护酶及其用途公开(公告)号:WO2005001047A8
公开(公告)日:2006-04-20
申请号:PCT/US2004017457
申请日:2004-06-03
Applicant: SQUIBB BRISTOL MYERS CO , NANDURI VENKATA B , PATEL RAMESH N , GOLDBERG STEVEN L , JOHNSTON ROBERT M
Inventor: NANDURI VENKATA B , PATEL RAMESH N , GOLDBERG STEVEN L , JOHNSTON ROBERT M
IPC: C12N20060101 , C07H21/04
CPC classification number: C12N9/78
-
6.STEREOSELECTIVE REDUCTION PROCESS FOR THE PREPARATION OF PYRROLOTRIAZINE COMPOUNDS 审中-公开
Title translation: 用于制备吡咯啉化合物的选择性缩合方法公开(公告)号:WO2006130657A3
公开(公告)日:2007-03-29
申请号:PCT/US2006021066
申请日:2006-05-31
Applicant: SQUIBB BRISTOL MYERS CO , PATEL RAMESH N , CHU LINDA NGA HOONG , JOHNSTON ROBERT M , GUO ZHIWEI , CHEN YIJUN , GOLDBERG STEVEN L , HANSON RONALD L , GOSWAMI ANIMESH , KATIPALLY KISHTA
Inventor: PATEL RAMESH N , CHU LINDA NGA HOONG , JOHNSTON ROBERT M , GUO ZHIWEI , CHEN YIJUN , GOLDBERG STEVEN L , HANSON RONALD L , GOSWAMI ANIMESH , KATIPALLY KISHTA
IPC: C12P17/12 , C07D487/04 , C12N9/02
CPC classification number: C12N9/0006 , C07D487/04 , C12P17/165
Abstract: The invention relates to a process for the enzymatic, stereoselective reduction of ketone compounds to provide chiral alcohols, for example the compound of formula (Ib).
Abstract translation: 本发明涉及一种用于酶化,立体选择性还原酮化合物以提供手性醇的方法,例如式(Ib)的化合物。
-
7.METHODS AND COMPOUNDS PRODUCING DIPEPTIDYL PEPTIDASE IV INHIBITORS AND INTERMEDIATES THEREOF 审中-公开
Title translation: 制备DIPEPTIDYL PEPTIDASE IV抑制剂的方法和化合物及其中间体公开(公告)号:WO2004052850A3
公开(公告)日:2006-03-02
申请号:PCT/US0338558
申请日:2003-12-04
Applicant: SQUIBB BRISTOL MYERS CO , VU TRUC CHI , BRZOZOWSKI DAVID B , FOX RITA , GODFREY JOLLIE DUAINE JR , HANSON RONALD L , KOLOTUCHIN SERGEI V , MAZZULLO JOHN A JR , PATEL RAMESH N , WANG JIANJI , WONG KWOK , YU JURONG , ZHU JASON , MAGNIN DAVID R , AUGERI DAVID J , HAMANN LAWRENCE G
Inventor: VU TRUC CHI , BRZOZOWSKI DAVID B , FOX RITA , GODFREY JOLLIE DUAINE JR , HANSON RONALD L , KOLOTUCHIN SERGEI V , MAZZULLO JOHN A JR , PATEL RAMESH N , WANG JIANJI , WONG KWOK , YU JURONG , ZHU JASON , MAGNIN DAVID R , AUGERI DAVID J , HAMANN LAWRENCE G
IPC: A61K31/403 , A61K31/435 , C07C62/06 , C07C69/00 , C07C69/716 , C07C229/28 , C07C271/22 , C07D20060101 , C07D201/00 , C07D207/22 , C07D207/277 , C07D209/02 , C07D209/52 , C07D221/02
CPC classification number: C07C69/757 , C07C62/06 , C07C69/635 , C07C69/675 , C07C229/28 , C07C271/22 , C07C2603/74 , C07D207/22 , C07D209/52
Abstract: Methods and compounds for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV are provided.
Abstract translation: 提供了用于制备二肽基肽酶IV的环丙基稠合吡咯烷基抑制剂的方法和化合物。
-
8.FUSED HETEROCYCLIC SUCCINIMIDECOMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION 审中-公开
Title translation: 融合杂环化合物及其类似物,核激素受体功能的调节剂公开(公告)号:WO03062241A8
公开(公告)日:2004-10-21
申请号:PCT/US0240598
申请日:2002-12-18
Applicant: SQUIBB BRISTOL MYERS CO , SALVATI MARK E , BALOG JAMES AARON , PICKERING DACIA A , GIESE SOREN , FURA ABERRA , LI WENYING , PATEL RAMESH N , HANSON RONALD L , MITT TOOMAS , ROBERGE JACQUES , CORTE JAMES R , SPERGEL STEVEN H , RAMPULLA RICHARD A , MISRA RAJ , XIAO HAI-YUN
Inventor: SALVATI MARK E , BALOG JAMES AARON , PICKERING DACIA A , GIESE SOREN , FURA ABERRA , LI WENYING , PATEL RAMESH N , HANSON RONALD L , MITT TOOMAS , ROBERGE JACQUES , CORTE JAMES R , SPERGEL STEVEN H , RAMPULLA RICHARD A , MISRA RAJ , XIAO HAI-YUN
IPC: C07D487/18 , A61K31/40 , A61K31/407 , A61K31/4155 , A61K31/416 , A61K31/4178 , A61K31/4184 , A61K31/4192 , A61K31/4196 , A61K31/422 , A61K31/423 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/433 , A61K31/437 , A61K31/439 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/4725 , A61K31/498 , A61K31/506 , A61K31/52 , A61K31/5377 , A61K31/7052 , A61P1/14 , A61P3/06 , A61P3/10 , A61P5/26 , A61P5/28 , A61P5/32 , A61P5/46 , A61P7/00 , A61P9/04 , A61P13/08 , A61P15/00 , A61P15/02 , A61P15/04 , A61P15/08 , A61P15/18 , A61P17/08 , A61P17/10 , A61P17/14 , A61P19/10 , A61P21/02 , A61P25/18 , A61P25/28 , A61P25/30 , A61P29/00 , A61P35/00 , A61P37/02 , C07D471/18 , C07D491/00 , C07D491/18 , C07D491/22 , C07D495/18 , C07D519/00 , C07H17/00
CPC classification number: C07D491/18 , C07D491/22 , C07D519/00
Abstract: Fused cyclic compounds method of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Abstract translation: 使用这些化合物治疗核激素受体相关病症如癌症和免疫疾病的融合的环状化合物的方法,以及含有这些化合物的药物组合物。
-
9.PICHIA PASTORIS FORMATE DEHYDROGENASE AND USES THEREFOR 审中-公开
Title translation: PICHIA PASTORIS FORMATE DEHYDROGENASE及其用途公开(公告)号:WO03054155A2
公开(公告)日:2003-07-03
申请号:PCT/US0240235
申请日:2002-12-16
Applicant: SQUIBB BRISTOL MYERS CO , GOLDBERG STEVEN L , CINO PAUL M , PATEL RAMESH N , NANDURI VENKATA B , JOHNSTON ROBERT M
Inventor: GOLDBERG STEVEN L , CINO PAUL M , PATEL RAMESH N , NANDURI VENKATA B , JOHNSTON ROBERT M
CPC classification number: C12N9/0004 , C12Q1/26 , G01N2333/04
Abstract: This invention relates to a recombinant Pichia pastoris formate dehydrogenase (FDH) enzyme that catalyzes the oxidation of formate to carbon dioxide and the simultaneous reduction of nicotinamide adenine dinucleotide (NAD+) to its reduced form (NADH). Also related are isolated nucleic acids encoding P. pastoris FDH polypeptides, and fragments and variants thereof, as well as vectors and host cells comprising these nucleic acids. Further related are isolated, recombinant P. pastoris FDH polypeptides, and fragments and variants thereof, and antibodies that specifically bind to P. pastoris FDH polypeptides, fragments, or variants. The invention also relates to methods of obtaining isolated P. pastoris FDH nucleic acids, polypeptides, and antibodies, and methods of using P. pastoris FDH in various reactions for industrial or pharmaceutical applications.
Abstract translation: 本发明涉及催化甲酸氧化成二氧化碳并同时将烟酰胺腺嘌呤二核苷酸(NAD +)还原为还原形式(NADH)的重组巴斯德毕赤酵母甲酸脱氢酶(FDH)酶。 还涉及编码巴斯德毕赤酵母多肽的分离的核酸及其片段和变体,以及包含这些核酸的载体和宿主细胞。 进一步相关的是分离的,重组的巴斯德毕赤酵母多肽,及其片段和变体,以及特异性结合巴斯德毕赤酵母多肽,片段或变体的抗体。 本发明还涉及获得分离的巴斯德毕赤氏酵母多肽和多肽的抗体的方法,以及在工业或制药的各种反应中使用巴斯德毕赤酵母多肽的方法 应用。
-
10.ENZYMATIC OXIDATIVE DEAMINATION PROCESS 审中-公开
Title translation: ENZYMATISCHES,OXIDATIVES DEAMINIERUNGSVERFAHREN公开(公告)号:EP1109928A4
公开(公告)日:2004-10-13
申请号:EP99945367
申请日:1999-08-31
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: PATEL RAMESH N , BANERJEE AMIT , NANDURI VENKATA B , GOLDBERG STEVEN L , JOHNSTON ROBERT M , TULLY THOMAS P , SZARKA LASZLO J , SWAMINATHAN SHANKAR , VENIT JOHN J , MONIOT JEROME L , WINTER WILLIAM J , ANDERSON NEAL G , LUST DAVID A , CRISPINO GERARD , SRIVASTAVA SUSHIL
IPC: C12N15/09 , A61K38/00 , C07D513/04 , C07K5/062 , C07K5/078 , C07K14/81 , C12N1/20 , C12N1/21 , C12N9/06 , C12N9/10 , C12P17/18 , C12R1/01 , C12R1/38 , C12R1/465 , C07K5/06 , C12N15/52 , C12P21/02
CPC classification number: C07K5/06139 , A61K38/00 , C07K14/8103 , C12N9/1096
-
-
-
-
-
-
-
-
-